Cargando…

Use of Clinical Pathway Simulation and Machine Learning to Identify Key Levers for Maximizing the Benefit of Intravenous Thrombolysis in Acute Stroke

Expert opinion is that about 20% of emergency stroke patients should receive thrombolysis. Currently, 11% to 12% of patients in England and Wales receive thrombolysis, ranging from 2% to 24% between hospitals. The aim of this study was to assess how much variation is due to differences in local pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allen, Michael, James, Charlotte, Frost, Julia, Liabo, Kristin, Pearn, Kerry, Monks, Thomas, Everson, Richard, Stein, Ken, James, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389935/ https://www.ncbi.nlm.nih.gov/pubmed/35862194 http://dx.doi.org/10.1161/STROKEAHA.121.038454

Ejemplares similares

What would other emergency stroke teams do? Using explainable machine learning to understand variation in thrombolysis practice
por: Pearn, Kerry, et al.
Publicado: (2023)

Can clinical audits be enhanced by pathway simulation and machine learning? An example from the acute stroke pathway
por: Allen, Michael, et al.
Publicado: (2019)

Feasibility of a hyper-acute stroke unit model of care across England: a modelling analysis
por: Allen, Michael, et al.
Publicado: (2017)

Planning and Providing Acute Stroke Care in England: The Effect of Planning Footprint Size
por: Allen, Michael, et al.
Publicado: (2019)

Optimizing sobriety checkpoints to maximize public health benefits and minimize operational costs
por: Morrison, Christopher N., et al.
Publicado: (2023)

Covid-19 and age discrimination: benefit maximization, fairness, and justified age-based rationing
por: Albertsen, Andreas
Publicado: (2022)

Long-Term Survival After Intravenous Thrombolysis for Ischemic Stroke: A Propensity Score-Matched Cohort With up to 10-Year Follow-Up
por: Muruet, Walter, et al.
Publicado: (2018)

Charles Lever
por: Winn, J. M.
Publicado: (1879)

Maximizing the benefits of antiretroviral therapy for key affected populations
por: Grubb, Ian R, et al.
Publicado: (2014)

Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
por: Tong, Xu, et al.
Publicado: (2020)

Compound Lever Forceps
Publicado: (1851)

Levers of Organizational Resilience
por: Schäffer, Utz
Publicado: (2020)

Characteristics and Outcomes of Thrombolysis-Treated Stroke Patients With and Without Saccular Intracranial Aneurysms
por: Virta, Jyri J., et al.
Publicado: (2022)

Ventricular Extension of Intracerebral Hemorrhage during Intravenous Thrombolysis
por: Harston, George W.J., et al.
Publicado: (2013)

Intravenous Thrombolysis Benefits Mild Stroke Patients With Large-Artery Atherosclerosis but No Tandem Steno-Occlusion
por: Wang, Dapeng, et al.
Publicado: (2020)

In-Hospital Intravenous Thrombolysis Offers No Benefit in Mechanical Thrombectomy in Optimized Tertiary Stroke Center Setting
por: Pienimäki, Juha-Pekka, et al.
Publicado: (2020)

Intravenous Thrombolysis in Posterior Circulation Stroke
por: Dorňák, Tomáš, et al.
Publicado: (2019)

Intravenous thrombolysis for bioprosthetic valve thrombosis
por: Adrichem, Rik, et al.
Publicado: (2023)

National implementation of reperfusion for acute ischaemic stroke in England: How should services be configured? A modelling study
por: Allen, Michael, et al.
Publicado: (2021)

The Magnification of the Frontal Writing Lever
por: Newton, W. H.
Publicado: (1944)

Granulome facial de Lever
por: Hjira, Naoufal, et al.
Publicado: (2013)

Spring Levers for Regulating Teeth
por: Davenport, W. S.
Publicado: (1898)

Literacy: A lever for citizenship?
por: Robinson-Pant, Anna
Publicado: (2023)

Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System
por: Nguyen-Huynh, Mai N., et al.
Publicado: (2018)

Complete renal recovery from severe acute renal failure after thrombolysis of bilateral renal vein thrombosis
por: Ramadoss, Suresh, et al.
Publicado: (2012)

Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial
por: Koga, Masatoshi, et al.
Publicado: (2020)

Age and Stroke Severity: Hazards for Intravenous Thrombolysis?
por: Long, Chuyan, et al.
Publicado: (2015)

“Calcified Clot March” after Intravenous Thrombolysis
por: Agarwal, Vivek, et al.
Publicado: (2020)

Intravenous Thrombolysis for a Stroke Mimic Patient
por: Nguyen, Lilly, et al.
Publicado: (2021)

Bridging intravenous thrombolysis in patients with atrial fibrillation
por: Mujanovic, Adnan, et al.
Publicado: (2022)

Biomechanical analysis of reduction technique for lumbar spondylolisthesis: anterior lever versus posterior lever reduction method
por: Lin, Yu-Tsung, et al.
Publicado: (2021)

Lithotrity, with a New Lever Lithotrite
por: Watson, Patrick Heron
Publicado: (1869)

Intravenous Thrombolysis in Chinese Patients with Different Subtype of Mild Stroke: Thrombolysis in Patients with Mild Stroke
por: Chen, Weiqi, et al.
Publicado: (2017)

The key to maximizing the benefits of antimicrobial and self-cleaning coatings is to fully determine their risks
por: Fu, Han, et al.
Publicado: (2021)

Intravenous Thrombolysis for Embolic Stroke due to Cardiac Myxoma
por: Sun, Mu-Chien, et al.
Publicado: (2011)

Variation in Clinical Practice of Intravenous Thrombolysis in Stroke in the Netherlands
por: Bauer, Auke, et al.
Publicado: (2013)

Intravenous Thrombolysis in a Stroke Patient Receiving Rivaroxaban
por: Fluri, Felix, et al.
Publicado: (2013)

Comparisons of outcomes in stroke subtypes after intravenous thrombolysis
por: Pan, Yi-Ting, et al.
Publicado: (2016)

No space left for intravenous thrombolysis in acute stroke: CONS
por: Muir, Keith
Publicado: (2016)

Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
por: Derex, Laurent, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fj0oijjg9hrtf78tq775mauidv